Convalescent plasma associates with reduced mortality and improved clinical trajectory in patients hospitalized with COVID-19-Reference-Cited by-同舟云学术

Convalescent plasma associates with reduced mortality and improved clinical trajectory in patients hospitalized with COVID-19

Published:2021-10-15 Issue:20 Volume:131 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Arnold Egloff Shanna A.,Junglen Angela,Restivo Joseph S.A.,Wongskhaluang Marjorie^ORCID,Martin Casey,Doshi Pratik,Schlauch Daniel,Fromell Gregg,Sears Lindsay E.^ORCID,Correll Mick,Burris Howard A.,LeMaistre Charles F.^ORCID

Funder

HCA Healthcare

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/151788/files/pdf

Reference40 articles.

1. Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study

2. Efficacy and safety of convalescent plasma therapy in severe COVID-19 patients with acute respiratory distress syndrome

3. Convalescent plasma therapy in patients with COVID-19

4. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review;Chai;Cochrane Database Syst Rev,2020

5. Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Avoided and avoidable deaths with the use of COVID-19 convalescent plasma in Italy during the first two years of pandemic;2024-08-12

2. Estimates of Actual and Potential Lives Saved in the United States from the use of COVID-19 Convalescent Plasma;2024-05-18

3. Evidence for the Efficacy of COVID-19 Convalescent Plasma;Current Topics in Microbiology and Immunology;2024

4. The Importance of Geographic Proximity of Convalescent Plasma Donors;Current Topics in Microbiology and Immunology;2024

5. Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial;BMJ Medicine;2023-10